Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shigeyuki Yokoyoma"'
Autor:
Miyuki Kato-Murayama, Tamami Uejima, Naomi Ohbayashi, Hiroshi Nojima, Mutsuko Kukimoto-Niino, Shigeyuki Yokoyoma, Noboru Ohsawa, Kazutaka Murayama, Mikako Shirouzu, Takayoshi Matsuda
Publikováno v:
ChemistryOpen, Vol 7, Iss 9, Pp 713-719 (2018)
ChemistryOpen
ChemistryOpen
Gefitinib is the molecular target drug for advanced non‐small‐cell lung cancer. The primary target of gefitinib is the positive mutation of epidermal growth factor receptor, but it also inhibits cyclin G‐associated kinase (GAK). To reveal the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2272832e711352642fc0dcbcd43db963
https://doaj.org/article/1792a4ab9ff142d693f1b4b82f51f702
https://doaj.org/article/1792a4ab9ff142d693f1b4b82f51f702
Autor:
Ohbayashi, Naomi1, Murayama, Kazutaka2,3, Kato‐Murayama, Miyuki2, Kukimoto‐Niino, Mutsuko2, Uejima, Tamami2, Matsuda, Takayoshi1, Ohsawa, Noboru1, Yokoyoma, Shigeyuki4, Nojima, Hiroshi5, Shirouzu, Mikako2 mikako.shirouzu@riken.jp
Publikováno v:
ChemistryOpen. Sep2018, Vol. 7 Issue 9, p713-719. 7p.